From Pharmacovigilance to Clinical Care Optimization.

Big Data / September 1, 2014
Leo Anthony Celi / Edward Moseley / Christopher Moses / Padhraig Ryan / Melek Somai / David Stone / Kai-ou Tang
Read original article
In order to ensure the continued, safe administration of pharmaceuticals, particularly those agents that have been recently introduced into the market, there is a need for improved surveillance after product release. This is particularly so because drugs are used by a variety of patients whose particular characteristics may not have been fully captured in the original market approval studies.
spotify logo
Not Playing - Spotify
Made with love from Milwaukee, and Tunis.